NDC 36000-326-02 5 mL Single-dose sterile vial
Palonosetron Hydrochloride Injection
0.25 mg/5 mL
For Intravenous Injection Only
Contents: *Each mL of aqueous solution contains palonosetron hydrochloride equivalent to 0.05 mg palonosetron. Each mL also contains 41.5 mg mannitol, 0.5 mg edetate disodium, 3.7 mg sodium citrate, 1.56 mg citric acid monohydrate and water for injection (q.s. to 1 mL). Hydrochloric acid or sodium hydroxide may have been added to adjust pH.
Store at 20º to 25ºC (68º to 77ºF); excursions permitted between 15º to 30°C (59º to 86°F) [see USP Controlled Room Temperature].
Protect from freezing. Protect from light.
Discard unused portion.
See package insert for dosage and administration information.
Baxter Oncology GmbH
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
| PALONOSETRON HYDROCHLORIDE |
palonosetron hydrochloride injection
|Labeler — Baxter Healthcare Corporation (005083209)|
|Registrant — Baxter Healthcare Corporation (005083209)|
|Baxter Oncology GmbH||344276063||MANUFACTURE (36000-326), ANALYSIS (36000-326), LABEL (36000-326), PACK (36000-326), STERILIZE (36000-326)|
Revised: 09/2020 Baxter Healthcare Corporation
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.